局限性头面部硬皮病的中枢神经系统表现:10例研究及文献回顾
本研究回顾性分析10例局限性头面部硬皮病伴神经影像异常患儿的临床与影像资料,最常见的神经影像异常为T2高信号、位于皮肤病变同侧的皮层下白质病变(占90%),结论与既往文献相似,在无新发或加重神经系统症状时,神经影像随访的作用尚不明确。
要点
- 局限性头面部硬皮病患儿神经影像最常见异常为T2高信号、位于皮肤病变同侧的皮层下白质病变(90%)。
- 钙化或血液产物(50%)、囊肿(40%)及异常强化(20%)也可观察到。
- 无新发或加重神经系统症状时,神经影像随访的作用尚不明确。
核心结论
- 本组结果与既往发表数据相似;在无新发或加重神经系统症状时,局限性头面部硬皮病神经影像随访的作用尚不明确。
研究设计与样本
- 经机构审查委员会批准后,通过影像数据库检索确定10例在本机构治疗的局限性头面部硬皮病伴神经影像异常患者,回顾性复习每例的神经影像检查与电子病历,并与既往研究比较。
关键影像表现/征象
- 磁共振成像上最常见的神经影像异常为T2高信号、位于皮肤病变同侧的皮层下白质病变(90%的病例)。
- 钙化或血液产物见于50%的病例,囊肿见于40%的病例,异常强化见于20%的病例。
- 1例PET扫描显示与MRI上主要信号异常灶对应的18F-氟脱氧葡萄糖(FDG)摄取减低。
- 30%的病例存在进展性神经影像异常。
临床应用与阅片要点
- 了解局限性头面部硬皮病常伴随的颅内神经影像异常,有助于将这些病变与其他表现相似的病变相鉴别。
- 治疗后神经系统症状变化与神经影像表现之间无一致关系。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Localized craniofacial scleroderma is a rare pediatric disease that involves a spectrum of discoloration, fibrosis and hemiatrophy of the face and scalp. Children with localized craniofacial scleroderma may have neurological symptoms, and in this context often undergo diagnostic imaging of the brain.
OBJECTIVE: To catalogue neuroimaging abnormalities in patients with localized craniofacial scleroderma treated at our institution, review their clinical courses and compare this data with prior studies.
MATERIALS AND METHODS: Following Institutional Review Board approval, an imaging database search identified 10 patients with localized craniofacial scleroderma and neuroimaging abnormalities treated at our institution. Neuroimaging exams and the electronic medical record were reviewed for each case.
RESULTS: The most common indications for neuroimaging were headache or seizure (80% of cases). The most common neuroimaging abnormalities were T2-hyperintense, subcortical white matter lesions ipsilateral to the cutaneous lesion (90% of cases) on magnetic resonance imaging (MRI). Calcifications or blood products (50%), cysts (40%) and abnormal enhancement (20%) were also observed. A positron emission tomography (PET) scan obtained for a single case demonstrated diminished 18F-fluorodeoxyglucose (FDG) avidity corresponding to the dominant focus of signal abnormality on MRI. Progressive neuroimaging abnormalities were present in 30% of cases. There was no consistent relationship between changes in neurological symptoms following treatment and neuroimaging findings.
CONCLUSION: Our results are similar to previously published data. In the absence of new or worsening neurological symptoms, the role of neuroimaging for follow-up of localized craniofacial scleroderma is unclear. Knowledge of intracranial neuroimaging abnormalities that are commonly associated with localized craniofacial scleroderma helps to distinguish these lesions from others that have similar appearance.
引用
- Maloney E, Menashe SJ, Iyer RS, et al. The central nervous system manifestations of localized craniofacial scleroderma: a study of 10 cases and literature review. Pediatr Radiol. 2018. PMID: 29971479. doi:10.1007/s00247-018-4177-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。